This study shows that exploiting genetic engineering of fd phage to develop tumor‐targeting‐phage‐templated PtNEs, with significantly higher catalytic activities than the non‐phage‐templated PtNEs, can achieve enhanced targeted cancer therapy. Here, ELP1 is linked to neoplasm.